12:00 AM
 | 
Feb 20, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ThermoDox heat-activated liposome: Phase II started

Celsion began a double-blind, sham-controlled, North American Phase II trial to compare 50 mg/m 2 IV ThermoDox plus radiofrequency ablation (RFA) vs. RFA alone in 88 patients with colorectal cancer metastasized to the liver....

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >